ATE80039T1 - Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten. - Google Patents

Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.

Info

Publication number
ATE80039T1
ATE80039T1 AT87113638T AT87113638T ATE80039T1 AT E80039 T1 ATE80039 T1 AT E80039T1 AT 87113638 T AT87113638 T AT 87113638T AT 87113638 T AT87113638 T AT 87113638T AT E80039 T1 ATE80039 T1 AT E80039T1
Authority
AT
Austria
Prior art keywords
dideoxycytidin
retrovirus
pharmaceutical composition
didehydrocytidin
dideoxy
Prior art date
Application number
AT87113638T
Other languages
English (en)
Inventor
Tai-Shun Lin
William H Prusoff
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE80039T1 publication Critical patent/ATE80039T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87113638T 1986-09-24 1987-09-17 Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten. ATE80039T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91120086A 1986-09-24 1986-09-24
EP87113638A EP0261595B1 (de) 1986-09-24 1987-09-17 Pharmazeutische Zusammensetzung, enthaltend 2',3'-Dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur Behandlung von mit Retrovirus infizierten Patienten

Publications (1)

Publication Number Publication Date
ATE80039T1 true ATE80039T1 (de) 1992-09-15

Family

ID=25429894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87113638T ATE80039T1 (de) 1986-09-24 1987-09-17 Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.

Country Status (18)

Country Link
EP (1) EP0261595B1 (de)
JP (2) JPH078796B2 (de)
KR (1) KR960001372B1 (de)
AT (1) ATE80039T1 (de)
AU (1) AU596864B2 (de)
CA (1) CA1304360C (de)
DE (1) DE3781488T2 (de)
DK (1) DK462687A (de)
EG (1) EG18441A (de)
ES (1) ES2052533T3 (de)
FI (1) FI874166A (de)
GR (1) GR3005870T3 (de)
IE (1) IE62103B1 (de)
IL (1) IL83944A (de)
NZ (1) NZ221893A (de)
PH (1) PH22990A (de)
PT (1) PT85755B (de)
ZA (1) ZA876411B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116822A (en) * 1986-10-24 1992-05-26 Stichting Rega Vzw Therapeutic application of dideoxycytidinene
JPS63107924A (ja) * 1986-10-25 1988-05-12 Yamasa Shoyu Co Ltd 抗レトロウイルス剤
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
JPH02152976A (ja) * 1988-05-06 1990-06-12 Bristol Myers Co ２´，３´―ジデヒドロ―２´，３´―ジデオキシヌクレオシドのプロドラッグ
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
EP0355031A3 (de) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
PL169106B1 (pl) * 1991-01-30 1996-06-28 Wellcome Found Sposób wytwarzania dyspergowalnej w wodzie tabletki PL PL PL PL PL PL PL
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
EP0788507B1 (de) * 1994-10-24 2004-12-15 Genencor International, Inc. L-pyranosyl-nukleoside

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
FR2528311B1 (fr) * 1982-06-14 1985-06-14 Synthelabo Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques
AU570855B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of in vitro infectivity and cytopathic effect of htlv-111/lav by 2' 3' -dideoxycytidine
EP0258412A1 (de) * 1986-02-20 1988-03-09 GREER, Sheldon B. Zubereitung und verfahren zur behandlung von aids und verwandten krankheiten

Also Published As

Publication number Publication date
IL83944A (en) 1993-01-31
FI874166A (fi) 1988-03-25
EG18441A (en) 1992-12-30
JPH07145058A (ja) 1995-06-06
PH22990A (en) 1989-02-24
GR3005870T3 (de) 1993-06-07
IE872562L (en) 1988-03-24
ES2052533T3 (es) 1994-07-16
EP0261595A3 (en) 1990-01-24
AU596864B2 (en) 1990-05-17
KR960001372B1 (ko) 1996-01-26
PT85755A (en) 1987-10-01
ZA876411B (en) 1988-03-18
IE62103B1 (en) 1994-12-14
DK462687A (da) 1988-03-25
AU7797787A (en) 1988-03-31
JPH078796B2 (ja) 1995-02-01
JPH0818986B2 (ja) 1996-02-28
CA1304360C (en) 1992-06-30
NZ221893A (en) 1990-11-27
KR880003626A (ko) 1988-05-28
DK462687D0 (da) 1987-09-04
DE3781488D1 (de) 1992-10-08
EP0261595B1 (de) 1992-09-02
FI874166A0 (fi) 1987-09-23
DE3781488T2 (de) 1993-02-18
PT85755B (pt) 1990-08-31
EP0261595A2 (de) 1988-03-30
IL83944A0 (en) 1988-02-29
JPS63146822A (ja) 1988-06-18

Similar Documents

Publication Publication Date Title
ATE77554T1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE80039T1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
DE69127615D1 (de) Transformierte Erythrozyten, Verfahren zu deren Herstellung, und ihre Verwendung in pharmazeutischen Zusammensetzungen
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DE3687895D1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee